Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Retained Earnings (2023 - 2026)

Beta Bionics' Retained Earnings history spans 4 years, with the latest figure at -$391.8 million for Q1 2026.

  • On a quarterly basis, Retained Earnings fell 20.42% to -$391.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$391.8 million, a 20.42% decrease, with the full-year FY2025 number at $403000.0, up 520.0% from a year prior.
  • Retained Earnings hit -$391.8 million in Q1 2026 for Beta Bionics, down from $403000.0 in the prior quarter.
  • Over the last five years, Retained Earnings for BBNX hit a ceiling of $403000.0 in Q4 2025 and a floor of -$391.8 million in Q1 2026.
  • Historically, Retained Earnings has averaged -$102.3 million across 4 years, with a median of $137000.0 in 2023.
  • Biggest five-year swings in Retained Earnings: crashed 52.55% in 2024 and later soared 520.0% in 2025.
  • Tracing BBNX's Retained Earnings over 4 years: stood at $137000.0 in 2023, then crashed by 52.55% to $65000.0 in 2024, then soared by 520.0% to $403000.0 in 2025, then plummeted by 97328.78% to -$391.8 million in 2026.
  • Business Quant data shows Retained Earnings for BBNX at -$391.8 million in Q1 2026, $403000.0 in Q4 2025, and $354000.0 in Q3 2025.